Effect of exercise on serum vitamin D and tissue vitamin D receptors in experimentally induced type 2 Diabetes Mellitus  by Aly, Yosria E. et al.
Journal of Advanced Research (2016) 7, 671–679Cairo University
Journal of Advanced ResearchORIGINAL ARTICLEEﬀect of exercise on serum vitamin D and tissue
vitamin D receptors in experimentally induced type
2 Diabetes Mellitus* Corresponding author. Fax: +20 4283719.
E-mail address: azzasaad_mri@yahoo.com (A.S. Abdou).
Peer review under responsibility of Cairo University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.jare.2016.07.001
2090-1232  2016 Production and hosting by Elsevier B.V. on behalf of Cairo University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Yosria E. Aly a, Azza S. Abdou a,*, Mona M. Rashad b, Menatallah M. Nassef baDepartment of Physiology, Medical Research Institute, Alexandria University, Alexandria, Egypt
bDepartment of Applied Medical Chemistry, Medical Research Institute, Alexandria University, EgyptG R A P H I C A L A B S T R A C TA R T I C L E I N F O
Article history:
Received 25 November 2015
Received in revised form 4 July 2016
Accepted 5 July 2016
Available online 15 July 2016A B S T R A C T
This work aimed to study the effect of swimming exercise on serum vitamin D level and tissue
vitamin D receptors in experimentally induced type 2 Diabetes Mellitus. Sixty adult male rats
were divided into control and diabetic groups. Each was further subdivided into sedentary
and exercised subgroups. Diabetes Mellitus was induced by a single intraperitoneal dose of
streptozotocin (50 mg/kg) dissolved in cold 0.01 M citrate buffer (pH 4.5). The exercised sub-
groups underwent swimming for 60 min, 5 times a week for 4 weeks. Serum glucose, insulin,
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Vitamin D receptorhomeostasis model assessment of insulin resistance (HOMA-IR), lipids, vitamin D and tissue
Vitamin D receptors (VDR) were evaluated. Significant increase in serum glucose, insulin,
HOMA-IR, cholesterol, triglycerides, and low density lipoprotein (LDL) levels in sedentary dia-
betic rats was detected. On the other hand, high density lipoprotein (HDL), free fatty acids,
serum vitamin D and pancreatic, adipose, and muscular VDR showed a significant decrease
in the same group. It is evident that all these parameters were reversed by swimming exercise
indicating its beneficial role in type 2 Diabetes. In diabetic groups; serum vitamin D was found
to be correlated negatively with serum glucose, insulin, HOMA, cholesterol, triglycerides, and
LDL and positively correlated with HDL and tissue VDR. In conclusion, Disturbed vitamin
D is associated with metabolic impairments in sedentary diabetic rats. Moderate swimming
exercise is beneficial in improving these consequences through modulation of vitamin D status.
Future studies could be designed to investigate the effect of the combination of vitamin D intake
with exercise in diabetic patients.
 2016 Production and hosting by Elsevier B.V. on behalf of Cairo University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Type 2 Diabetes Mellitus (DM) is an epidemic non-
communicable disease that threatens health and life quality
of people. Currently, there are 285 million people worldwide
living with diabetes, and 90–95% have type 2 DM. This num-
ber is expected to reach 439 million by the year 2030 [1]. Type 2
DM is a multifactorial disease characterized by chronic hyper-
glycemia, altered insulin secretion, and insulin resistance. It
can be also defined by impaired glucose tolerance (IGT) that
results from islet b cell dysfunction, followed by insulin defi-
ciency in skeletal muscle, liver and adipose tissues [2].
Apart from its calcemic effects, vitamin D is now known to
have many non-calcemic functions through which it may have
some roles in several human pathologies including some can-
cers, autoimmune and metabolic disorders [3]. A novel associ-
ation with diabetes that has received a considerable attention
recently is vitamin D disturbance. Some evidences indicate a
high prevalence of vitamin D deficiency worldwide. Vitamin
D deficiency is usually caused by low dietary vitamin D intake
and reduced cutaneous production of vitamin D [4]. The most
abundant form of vitamin D is 25-hydroxyvitamin D (25(OH)
D3), which indicates serum concentrations of vitamin D status.
It exerts its biological effects through the active metabolite 1a-
25 dihydroxy vitamin D3, which serves as a ligand for vitamin
D receptors (VDR) [5]. Alvarez and Ashraf [6] demonstrated
the expression of (VDRs) in pancreatic, muscle and adipose
tissue. It is hypothesized that vitamin D may have a role in
the pathogenesis and prevention of type 2 DM [7].
Swimming exercise is widely used in rats as a model for
evaluating the effects of aerobic activity in pathological and
physiological conditions [8]. The role of regular physical train-
ing on cardiovascular and metabolic disorders, including dia-
betes has been assessed [9]. However, little is known about
the effect of exercise on vitamin D status in case of type 2
DM. Therefore, the current study was conducted to evaluate
the effect of swimming exercise on serum vitamin D level
and tissue vitamin D receptors in experimentally induced type
2 DM Mellitus in rats.
Material and methods
All procedures were performed in accordance with ethical guide-
lines of Medical Research Institute, Alexandria University, for
the care and use of laboratory animals, (IORG0008812).Animals and experimental design
The present study was carried out on sixty adult male albino-
rats. Rats were obtained from the animal house of Medical
Research Institute, Alexandria University. They were housed
under controlled environmental conditions: temperature 25 C
with an established photo-period of 12 h light/day. The rats
had free access to food and tap water adlibitum. Rats were
divided randomly equally into 2 main groups:
Group I (control group): 30 males rats which were equally
subdivided into the following:
 Group I (a): control sedentary
 Group I (b): control exercised
Group II (diabetic group): 30 males rats that were equally
subdivided into the following:
 Group II (a): diabetic sedentary
 Group II (b): diabetic exercised
Induction of type 2 Diabetes Mellitus
To develop a rat model of experimentally-induced type 2 Dia-
betes Mellitus, which resembles that occurring in human pop-
ulation, overnight fasting rats were injected with a single
intraperitoneal (IP) dose of streptozotocin STZ (50 mg/kg)
(Sigma, St. Louis, MO, USA) dissolved in cold fresh 0.01 M
citrate buffer fresh or frozen in 1 mL aliquots at 20 C
(0.1 mol/L citric acid, 0.1 mol/L sodium citrate), pH 4.5. Dia-
betes was confirmed 3 days later when blood glucose rose
above 126 mg/dL [10].Swimming exercise protocol
The swimming moderate exercise protocol used included 2
phases: adaptation and training. The adaptation phase
included the first three days of training. On the first day, the
animals exercised in the pool (area 100 cm2, with water depth
35–45 cm at 37 C) for 15 min. The exercise period was
extended by 15 min each day until animals were swimming
for 60 min. The training phase consisted of 60 min session, 5
times a week for 4 weeks [11].
Exercise, vitamin D & diabetes 673At the end of the experiment, weight and length of each rat
were estimated with the calculation of anthropometric mea-
surements: body mass index (BMI) and Lee index. Then rats
were decapitated, blood samples were collected and cen-
trifuged and sera were separated into 2 aliquots; one part
was used immediately for assay of biochemical measurements
and the other part was stored at 20 C for the assay of serum
vitamin D and insulin hormone. The pancreas, skeletal muscle
and adipose tissues were excised from each rat and prepared
for vitamin D receptors assay.
Tissue preparation
The excised tissues were rinsed with ice-cold phosphate-buf-
fered saline (PBS) (0.02 mol/L, pH 7.0–7.2) to remove excess
blood thoroughly, then minced into small pieces and homoge-
nized in 10 mL of PBS with a glass homogenizer on ice. The
resulting suspension was subjected to two freeze-thaw cycles
to further break the cell membranes. After that, the homoge-
nates were centrifuged for 5 min at 5000 rpm and the super-
natant of each was removed and then stored at 20 C until
assay of vitamin D receptors.
Methods
The following parameters were determined for each rat.
Anthropometric measurements
 Body mass index (BMI) Body mass index (gm/cm2)
= weight (g)/total length2 (cm)2 [12].
 Lee index (g/cm) Lee index = cube root of body weight (g)/
nose-to-anus length (cm) [12].
Biochemical measurements
 Serum glucose [13].
 Serum insulin level using rat specific Enzyme linked
immune sorbent assay (ELISA) kits purchased from DRG
International Inc, USA.
 Assessment of insulin resistance using the homeostasis
model assessment (HOMA-IR score) using the equation
(fasting glucose (mmole/L)  fasting insulin (lU/L)/22.5)
[14].
 Serum cholesterol level [15].
 Serum triglycerides level [16].
 Serum High Density Lipoprotein (HDL.C) level [17].
 Serum Low Density Lipoprotein (LDL.C) level [18].
 Free Fatty Acid (FFA) level [19].
Vitamin D status assays
Serum vitamin D level and tissue VDR in the pancreas, muscle
and adipose tissue of each rat were determined using ELISA
kits purchased from Uscn life science Inc., USA.
Statistical analysis
Data were analyzed using IBM Statistical Package for Social
Sciences (SPSS) software package version 20.0. Data were firsttested for normality. The quantitative data were normally dis-
tributed and expressed in means and standard deviations.
Comparison between the different studied groups was ana-
lyzed using F test, Analysis of Variance (ANOVA) and Post
Hoc test (LSD) (Tukey) for pairwise comparisons. Pearson
correlation was also performed between serum vitamin D
and the other studied parameters. For all statistical tests, the
level of P equal to or less than 5% was considered significant.
Results
The comparison among the four studied groups (sedentary
control, exercised control, sedentary diabetic and exercised
diabetic) was done using ANOVA test and the Pairwise com-
parison between each two groups was done using Post Hoc test
(LSD) (Tukey). Findings of anthropometric and biochemical
measurements are summarized in Tables 1 and 2. As regards
BMI and Lee index, significant differences are noticed
(F= 13.42, 15.45 and P 6 0.001). Findings of serum glucose
level, fasting serum insulin and HOMA-IR demonstrated sig-
nificant differences among the four groups by ANOVA
(F= 70.11, 241.18 and 185.18 respectively) with P 6 0.001
(Table 1). In addition, significant differences among the four
groups were also noticed in serum cholesterol, triglycerides,
HDL, LDL and FFA (F= 260.49, 51.99, 22.79, 240,86 and
30.690 respectively) with P 6 0.001 (Table 2). The sedentary
diabetic group showed the most significant increase in serum
glucose, insulin, HOMA–IR, serum cholesterol, TG and
LDL as compared to the other groups. It showed also the most
significant decrease in serum HDL and FFA.
As shown in Table 3, significant differences were found
between the four groups in serum vitamin D and tissue vitamin
D receptors in pancreatic, muscle and adipose tissues (F val-
ues = 64.53, 66.17, 40, 74 and 95.13 respectively) with
P 6 0.001. The most significant decrease in serum vitamin D
and tissue VDR is observed in the sedentary diabetic group
as compared to the other groups. The P1–P6 values for pair-
wise comparisons of each two groups are shown in Tables 1–3.
Exercise induced a significant increase in muscle and adi-
pose tissue vitamin D receptors in both diabetic and control
groups as compared to sedentary one while a significant
increase in serum vitamin D and pancreatic receptors was
noticed in the exercised diabetic group only (Figs. 1–4).
Correlations between serum vitamin D and the other stud-
ied parameters in both sedentary and exercised diabetic groups
are represented in Table 4. Findings showed a positive correla-
tion between serum vitamin D and tissue VDR. On the other
hand, negative correlations were noticed between serum vita-
min D and the other studied parameters in both diabetic
groups.
Discussion
Vitamin D deficiency has reached epidemic proportions world-
wide primarily due to the shift to sedentary indoor lifestyles
and sun avoidance behaviors. Impacts on calcium metabolism
and bone health are well known; however, non-skeletal associ-
ations with chronic health problems are recently recognized.
Increasing evidence suggested also the relationship between
vitamin D and many metabolic diseases including diabetes.
Type 2 DM and vitamin D deficiency have risk factors in com-
Table 1 Anthropometric parameters and biochemical measurements in control and diabetic groups (Mean ± SD).
Group I (Control) (n= 30) Group II (Diabetic) (n= 30) F P
Group I (a)
Sedentary (n= 15)
Group I (b)
Exercised (n= 15)
Group II (a)
Sedentary (n= 15)
Group II (b)
Exercised (n= 15)
BMI (g/cm2) 0.53 ± 0.06 0.65 ± 0.06 0.53 ± 0.06 0.53 ± 0.07 13.423 <0.001*
Sig. bet. grps P1 < 0.001
*, P2 = 0.999, P3 = 0.990, P4 < 0.001
*, P5 < 0.001
*, P6 = 0.998
Lee index (g/cm) 0.73 ± 0.040 0.81 ± 0.04 0.73 ± 0.04 0.73 ± 0.03 15.466 <0.001*
Sig. bet. grps P1 < 0.001
*, P2 = 1.000, P3 = 1.000, P4 < 0.001
*, P5 < 0.001
*, P6 = 1.000
Serum glucose (mg/dL) 87.80 ± 11.06 90.47 ± 10.67 165.40 ± 24.76 137.20 ± 19.13 70.112 <0.001*
Sig. bet. grps P1 = 0.975, P2 < 0.001
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 < 0.001
*
Serum insulin (lg/L) 9.72 ± 1.89 10.93 ± 1.69 29.27 ± 3.45 22.80 ± 1.97 241.175 <0.001*
Sig. bet. grps P1 = 0.506, P2 < 0.001
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 < 0.001
*
HOMA-IR 2.11 ± 0.53 2.43 ± 0.46 11.94 ± 2.30 7.70 ± 1.16 185.175 <0.001*
Sig. bet. grps P1 = 0.911, P2 < 0.001
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 < 0.001
*
F(P). P value for F test (ANOVA), Sig. bet. grps were done using Post Hoc Test (Tukey).
P1: P value for comparing between Group I (a) Sedentary and Group I (b) Exercised.
P2: P value for comparing between Group I (a) Sedentary and Group II (a) Sedentary.
P3: P value for comparing between Group I (a) Sedentary and Group II (b) Exercised.
P4: P value for comparing between Group I (b) Exercised and Group II (a) Sedentary.
P5: P value for comparing between Group I (b) Exercised and Group II (b) Exercised.
P6: P value for comparing between Group II (a) Sedentary and Group II (b) Exercised.
* Statistically significant at P 6 0.05.
Table 2 Lipid profiles in control and diabetic groups (Mean ± SD).
Group I (Control) (n= 30) Group II (Diabetic) (n= 30) F P
Group I (a)
Sedentary (n= 15)
Group I (b)
Exercised (n= 15)
Group II (a)
Sedentary (n= 15)
Group II (b)
Exercised (n= 15)
Cholesterol (mg/dL) 91.33 ± 11.90 73.27 ± 8.93 174.4 ± 14.53 154.8 ± 10.72 260.497 <0.001*
Sig. bet. grps P1 < 0.001
*, P2 < 0.001
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 < 0.001
*
Triglycerides (mg/dL) 81.40 ± 17.2 53.47 ± 7.24 118.0 ± 18.74 76.33 ± 11.43 51.994 <0.001*
Sig. bet. grps P1 < 0.001
*, P2 < 0.001
*, P3 = 0.769, P4 < 0.001
*, P5 < 0.001
*, P6 < 0.001
*
HDL (mg/dL) 25.0 ± 3.72 36.07 ± 6.23 21.67 ± 4.19 32.47 ± 6.73 22.797 <0.001*
Sig. bet. grps P1 < 0.001
*, P2 = 0.334, P3 = 0.002
*, P4 < 0.001
*, P5 < 0.001
*, P6 = 0.268
LDL (mg/dL) 50.05 ± 12.83 26.51 ± 9.05 129.13 ± 14.69 107.3 ± 10.47 240.857 <0.001*
Sig. bet. grps P1 < 0.001
*, P2 < 0.001
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 < 0.001
*
FFA (mmol/L) 4.85 ± 1.26 7.80 ± 2.21 2.29 ± 0.78 4.65 ± 1.70 30.687 <0.001*
Sig. bet. grps P1 < 0.001
*, P2 < 0.001
*, P3 = 0.987, P4 < 0.001
*, P5 < 0.001
*, P6 = 0.001
*
F(P). P value for F test (ANOVA), Sig. bet. grps were done using Post Hoc Test (Tukey).
P1: P value for comparing between Group I (a) Sedentary and Group I (b) Exercised.
P2: P value for comparing between Group I (a) Sedentary and Group II (a) Sedentary.
P3: P value for comparing between Group I (a) Sedentary and Group II (b) Exercised.
P4: P value for comparing between Group I (b) Exercised and Group II (a) Sedentary.
P5: P value for comparing between Group I (b) Exercised and Group II (b) Exercised.
P6: P value for comparing between Group II (a) Sedentary and Group II (b) Exercised.
* Statistically significant at P 6 0.05.
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Table 3 Serum vitamin D, pancreatic VDR, skeletal mu le VDR and adipose VDR in control and diabetic groups (Mean ± SD).
Group I ontrol) (n= 30) Group II (Diabetic) (n= 30) F P
Group I (a)
Sedentary (n= 15)
Group I (b)
Exercised (n= 15)
Group II (a)
Sedentary (n= 15)
Group II (b)
Exercised (n= 15)
Serum VD (nmol/L) 9.59 ± 0.79 9.79 ± 2.60 3.27 ± 0.11 6.12 ± 1.38 64.526 <0.001*
Sig. bet. grps P1 = 0.903, P2 < 0 01
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 = 0.001
*
Pancreatic VDR (ng/mL) 19.48 ± 5.02 22.36 ± 2.79 6.98 ± 2.11 13.10 ± 2.29 66.169 <0.001*
Sig. bet. grps P1 = 0.086, P2 < 0 01
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 = 0.001
*
Skeletal muscle VDR (ng/mL) 23.87 ± 2.92 30.07 ± 3.37 16.60 ± 4.22 21.16 ± 2.99 40.739 <0.001*
Sig. bet. grps P1 = 0.048
*, P2 < 01
*, P3 < 0.001
*, P4 < 0.001
*, P5 < 0.001
*, P6 = 0.001
*
Adipose VDR (ng/mL) 21.67 ± 2.09 23.68 ± 2.40 12.19 ± 1.26 16.30 ± 2.33 95.130 <0.001*
Sig. bet. grps P1 6 0.001*, P2 < 01*, P3 = 0.143, P4 < 0.001*, P5 < 0.001*, P6 = 0.003*
F(P). P value for F test (ANOVA), Sig. bet. grps were done u ng Post Hoc Test (Tukey).
P1: P value for comparing between Group I (a) Sedentary an Group I (b) Exercised.
P2: P value for comparing between Group I (a) Sedentary an Group II (a) Sedentary.
P3: P value for comparing between Group I (a) Sedentary an Group II (b) Exercised.
P4: P value for comparing between Group I (b) Exercised an roup II (a) Sedentary.
P5: P value for comparing between Group I (b) Exercised an roup II (b) Exercised
P6: P value for comparing between Group II (a) Sedentary an Group II (b) Exercised.
* Statistically significant at P 6 0.05.
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Fig. 4 Adipose tissue vitamin D receptor (VDR) (ng/mL) in
control and diabetic rats. *: Statistically significant at P 6 0.05.
676 Y.E. Aly et al.type 2 DM. This is clearly evident from the negative correla-
tions obtained between serum vitamin D levels and serum glu-
cose, insulin, HOMA.
Vitamin D may have beneficial effects on insulin action
either directly by stimulating the expression of insulin recep-
tors and enhancing insulin responsiveness for glucose trans-
port or indirectly via its role in regulating extracellular
calcium ensuring normal calcium influx through cell mem-
branes and adequate intracellular cytosolic calcium pool. Cal-
cium is essential for insulin-mediated intracellular processes in
insulin-responsive tissues such as skeletal muscle and adipose
tissue [21].
Vitamin D deficiency may influence insulin secretion and
sensitivity via its effects on intracellular calcium. The elevated
intracellular calcium impairs post-receptor binding insulin
action, such as the dephosphorylation of glycogen synthase
and of insulin regulatable GLUT-4 [22]. Vitamin D deficiency
also results in elevated parathyroid hormone (PTH) which in
turn is known to elevate intracellular calcium. Sustained eleva-
tions of intracellular calcium may inhibit insulin-target cells
from sensing the brisk intracellular calcium fluxes necessary
for insulin action, such as glucose transport. In addition, Vita-
min D deficiency may result in increased insulin resistance due
to the expression of pro-inflammatory cytokines involved inTable 4 Correlation between serum vitamin D with different param
Group II (a) sedentary
r P
Glucose 0.618* 0
Insulin 0.544* 0
HOMA 0.614* 0
Cholesterol 0.592* 0
Triglycerides 0.568* 0
HDL 0.538* 0
LDL 0.655* 0
Pancreatic VDR 0.586* 0
Skeletal muscle VDR 0.534* 0
Adipose VDR 0.623* 0
r: Pearson coefficient.
* Statistically significant at P 6 0.05.insulin resistance such as interleukins, IL-1, IL-6, and TNF-
a [23].
The identification of Vitamin D receptors in several tissues
provides a direct pathway for Vitamin D to impact upon struc-
ture and function of these tissues [24].
In the present work, vitamin D deficiency in the sedentary
diabetic group is associated with deficient tissue vitamin D
receptors (pancreas, muscle and adipose tissue). This finding
indicates that these tissues could be target organs for vitamin
D.
The potential influence of vitamin D on glucose homeosta-
sis was explained by the presence of specific vitamin D recep-
tors. The presence of these receptors and vitamin D–binding
proteins (DBP) in pancreatic tissue as well as the relationship
between certain allelic variations in the VDR and DBP genes
with glucose tolerance and insulin secretion has further
supported this hypothesis. Pancreatic b-cells express not
only VDR but also the pivotal enzyme 1a-hydroxylase
which catalyzes the conversion of 25(OH)D3 to 1, 25-
dihydroxyvitamin D (1, 25(OH)2D3) [24].
According to this, Palomer et al. [3] reported that the
mechanism of action of vitamin D in type 2 DM is thought
to be mediated not only through regulation of plasma calcium
levels, which regulate insulin synthesis and secretion, but also
through a direct action on pancreatic b-cell function.
VDRs are also expressed by both human skeletal muscle
and adipose tissue which are the main determinants of periph-
eral insulin sensitivity. These tissues were also shown to
express the 1a-hydroxylase gene in male Wistar rats [25]. The
significant decrease in muscular and adipose tissue VDR
obtained in the present study is associated with deficient serum
vitamin D levels in the sedentary diabetic group.
Dirks-Naylor and Lennon-Edwards [26] also reported that
the direct effects of vitamin D on muscle have to be connected
with VDR. Vitamin D affects muscle function through the
binding of 1, 25(OH)2D3 to its receptor resulting in muscle
growth as well as other adaptations. The low vitamin D status
is associated with loss of handgrip strength and impaired lower
extremity function with increased risk of falls [26].
An important mediator of vitamin D action is VDR gene
which functions as a transcription factor when bound to 1,
25(OH)2D3. It is proposed that genetic changes or alterationseters in diabetic groups.
Vitamin D
Group II (b) exercised
r P
.014 0.595* 0.019
.036 0.603* 0.017
.015 0.610* 0.016
.020 0.580* 0.023
.027 0.633* 0.011
.039 0.666* 0.007
.008 0.697* 0.004
.022 0.727* 0.002
.040 0.741* 0.002
.013 0.708* 0.003
Exercise, vitamin D & diabetes 677of VDR gene might contribute to the development of Diabetes
Mellitus by at least four different pathways: alteration in cal-
cium metabolism, modulation of adipocyte function, modula-
tion of insulin secretion and modification of cytokine
expression [3].
It has been reported that supplementation with vitamin D
in deficient rabbits that present with impaired insulin secretion
could correct this defect [6]. Moreover, Al-Sofiani et al. [27]
demonstrated that vitamin D supplement for 12 weeks
increased serum vitamin D concentrations and improved b-
cell activity in vitamin D-deficient type 2 DM which suggests
the possible role of vitamin D in the improvement of insulin
secretion and sensitivity.
On the other hand, Haroon et al. [28] have reported that the
currently available evidence based on randomized controlled
trials and longitudinal studies suggests that vitamin D supple-
mentation might not improve hyperglycemia, beta cell secre-
tion or insulin sensitivity in patients with established type 2
DM. Factors related to vitamin D and diabetes may be attrib-
uted; One factor linked to vitamin D is related to its dosing.
Sub optimal dosing of vitamin D may be one potential reason.
The dose of vitamin D used may not have been adequate; most
studies used daily doses of less than 2000 IU and daily doses
up to 5000 IU may be essential to raise serum 25(OH)D3 levels
above the 75-nmol/L level. The appropriate dose of vitamin D
that can achieve non-skeletal benefits still remains unclear. As
observed in some studies, supra-physiological dosing of vita-
min D may have been harmful. Genetic factors related to vita-
min D metabolism might play a role. It is likely that some
ethnic groups might have a lower sensitivity to the effects of
vitamin D and PTH [28].
Our findings demonstrated also the association between
vitamin D deficiency and dyslipidemia in sedentary diabetic
groups. Bellan et al. [29] suggested that lipid profile clearly
reflected vitamin D status, and high 25(OH)D3 levels were sig-
nificantly associated with higher levels of HDL cholesterol.
This seems to confirm that vitamin D status is inversely related
to atherogenic dyslipidemia and indicates that vitamin D may
be independently protective against the atherogenic profile in
diabetic patients.
Two main mechanisms have been postulated for vitamin D
mediated reduction in serum triglycerides. The first mechanism
is that vitamin D increases serum calcium by enhancing intesti-
nal calcium absorption. This calcium could then reduce serum
triglycerides by reducing hepatic triglyceride formation and
secretion. The second mechanism is that vitamin D has a sup-
pressive effect on serum PTH concentration. As plasma post-
heparin lipolytic activity is reduced by elevated PTH concen-
tration, low serum PTH may reduce serum triglycerides via
increased peripheral removal. Other two mechanisms may be
also implicated: Vitamin D may regulate triglyceride metabo-
lism by causing the expression of VLDL cholesterol receptors
in some types of cell. Another possible mechanism to explain
the association between 25-hydroxyvitamin D and triglycerides
would be through insulin resistance: when vitamin D defi-
ciency is present, the risk of insulin resistance increases and
this is associated with an elevation of levels of VLDL choles-
terol and triglycerides [30].
The results of this study showed that low vitamin D levels
are associated with diabetes, independently of BMI. Our
findings demonstrated that there is no change in markers ofadiposity (BMI and Lee index) in the sedentary diabetic group.
In addition, these were not correlated with vitamin D levels.
Contrary to this, the association of obesity with low vita-
min D was previously reported. The high content of body fat
acts as a reservoir for lipid soluble vitamin D and increases
its sequestration, thus determining its low bioavailability.
Moreover, the synthesis of 25-hydroxyvitamin D by the liver
may occur at a lower rate in obese subjects due to hepatic
steatosis. An alternative explanation is that higher leptin and
interleukin 6 circulating levels, mostly secreted by adipose tis-
sue, may have inhibitory effects on 25(OH)D3 synthesis via
their receptors [31].
Experimental studies showed that 1, 25(OH)2D3 has an
active role in adipose tissue on vitamin D by modulating
inflammation, adipogenesis and adipocyte secretion. Some of
the physiological functions of 1, 25(OH)2D3 (1,25-
dihydroxycholecalciferol or calcitriol) via its receptors within
the adipose tissue have been reported. The presence of 1,25
(OH)2D3 inhibited chemokine and cytokine secretion in
human adipocytes. 1,25(OH)2D3 strongly inhibits the activa-
tion of the NF-jB and MAPK signaling pathways, which pre-
vents gene transcription of the proinflammatory factors [32].
Exercise and physical activity are considered as the most
effective, non-pharmacological interventions in metabolic dis-
eases as diabetes. However, little is known about the underly-
ing mechanism and the role of vitamin D coordinating these
adaptations.
It was reported that regular physical activity increases the
physical strength of diabetic patients, controls blood glucose,
and prevents the progression from impaired glucose tolerance
to type 2DM. Physical activity also enhances insulin sensitivity
in the liver, resulting in reduced glucose production and output
in the presence of insulin. Due to this connection, the Ameri-
can Diabetes Association (ADA) recommends aerobic exercise
of medium intensity such as 150 min of walking per week, or
75 min of high intensity aerobic exercise per week for patients
with type 2 DM [33].
It has been reported that regular physical activity is the
most effective method for improving insulin resistance. Aero-
bic exercise was reported to have a positive effect on the insulin
resistance index by inducing the oxidation of fatty acids as well
as an increase in insulin sensitivity [33].
Improving vitamin D status with modest lifestyle modifica-
tions was recently suggested. The National Health and Nutri-
tion Examination Survey (NHANES III) reports indicated
that physical activity is related to serum 25(OH)D3 either
due to enhanced vitamin D metabolism or increased sun expo-
sure. Wanner et al. [34] reported significantly higher levels of
25(OH)D3 in those who exercised outdoors than in those
who exercised indoors.
The present study revealed that swimming exercise in dia-
betic rats was effective in improving vitamin D status resulting
in significantly higher serum vitamin D levels associated with
increased vitamin D receptors in muscle, pancreas and adipose
tissue. The obtained inverse correlations between vitamin D
levels with serum glucose, insulin and HOMA indicate that
moderate exercise could enhance vitamin D formation which
in turn increases insulin sensitivity, reduce glucose and insulin
levels.
Muscular atrophy is a well-known complication of chronic
human diabetes and commonly affects the lower limb muscles.
678 Y.E. Aly et al.Swimming exercise ameliorates the atrophy of muscles by sup-
pressing autophagy. Regular physical activity leads to a num-
ber of adaptations in skeletal muscle that allow the muscle to
more efficiently utilize substrates for ATP production and thus
become more resistant to fatigue. Chronic physical activity
(i.e., exercise training) increases glucose transporter 4
(GLUT4) protein levels and mitochondrial enzyme content,
and alters fiber type in skeletal muscle [9].
The present study demonstrated also a significant decrease
in lipid profile parameters (TC, TG, LDL-C) with significantly
increased levels of HDL-C in diabetic rats with swimming
exercise. Additionally, the increased vitamin D levels and
VDR were negatively correlated with TC, TG and LDL-C
and positively correlated with HDL-C plasma levels.
There are three possible mechanisms by which increased
vitamin D-VDR axis by exercise could improve lipid profiles:
first: vitamin D-induced suppression of PTH secretion, and
so increase in lipolysis; second: vitamin D can trigger a
decrease in serum triglycerides levels by reducing the hepatic
triglyceride formation and secretion and third: vitamin D
might improve insulin secretion and insulin sensitivity, thereby
indirectly influencing lipid metabolism [30].
Some cross-sectional studies indicate that hypo-vitaminosis
D is associated with higher serum levels of inflammatory
biomarkers, such as IL-6. The relationship between vitamin
D and low-intensity chronic inflammation with insulin resis-
tance in type 2 DM can be mediated in part by the immune-
modulating properties of the 1, 25(OH)2D3, which is able to
downregulate the production of pro-inflammatory cytokines.
1, 25(OH)2D3 may induce its biologic responses through a
high-affinity intracellular VDR and so, lacking of the VDR
induced the pro-inflammatory responses followed by high
intrinsic NF-kB activity [31,32]. Therefore, vitamin D may also
function to reduce the risk of diabetes by acting to reduce
inflammatory responses.
Moreover, it was reported that exercise training is associ-
ated with systemic anti-inflammatory effects, with a reduction
in pro-inflammatory markers such as IL-6 and TNF-a in
plasma [35]. Therefore, improvement of the studied metabolic
parameters in diabetic rats by exercise could be due to the
anti-inflammatory response obtained by the modulated vita-
min D and enhancement of its VDR. However, the present
study did not investigate how inflammation is related to the
improved vitamin D status. This is likely to be studied in the
near future.Conclusions
In conclusion, data of the present study demonstrate hypo-
vitaminosis D in sedentary type 2 DM groups. Current find-
ings support the importance of vitamin D in contributing to
metabolic homeostasis and suggesting its possible role in regu-
lation of glucose homeostasis, insulin and lipid metabolism.
The interaction of non-skeletal VDR with type 2 DM patho-
genesis is also suggested. Moderate swimming exercise may
be beneficial in improving serum vitamin D and its receptors.
Type 2 DM patients should maintain serum vitamin D at nor-
mal levels by regular monitoring. An aquatic exercise program
with an appropriate intensity should be also recommended in
those subjects.Future studies could be designed to investigate the effect of
the combination of vitamin D intake with exercise in diabetic
patients. Investigation of the role of vitamin D in diabetes
using inflammation as the main outcome is needed to provide
a more pathophysiological link. Moreover, it is important to
examine more genetic polymorphism on a larger sample size
to identify individuals that are more susceptible to vitamin D
deficiency.
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